Salivary Gland High Grade Carcinoma — Trials

Salivary Gland High Grade Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

9 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Radboud University Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04249947	P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)	terminated	Phase 1	40	Poseida Therapeutics, Inc.INDUSTRY	1	Feb 17, 2025	clinicaltrials
NCT00126607	Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer	terminated	Phase 2	35	National Cancer Institute (NCI)NIH	1	Feb 28, 2013	clinicaltrials